{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:31:31Z","timestamp":1780587091447,"version":"3.54.1"},"reference-count":71,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,31]],"date-time":"2006-01-31T00:00:00Z","timestamp":1138665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2006,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Given the high mortality rate and the rapidly increasing incidence rate of esophageal carcinoma, chemopreventive agents are highly desirable. Aspirin has been shown to be associated with reduced risk of developing colorectal carcinoma and other cancers. Even though previous studies have shown reduced risk of esophageal cancer associated with aspirin use, results were inconsistent with respect to frequency and duration of use. In this hospital\u2010based case\u2010control study, 163 esophageal cancer cases were compared to 482 age\u2010 and sex\u2010matched hospital controls with nonneoplastic conditions. Participants were classified as regular aspirin users if they had taken the drug at least once a week for 6 months. Results suggest that esophageal cancer risk is significantly lower for regular aspirin users compared to nonusers [adjusted odds ratio (aOR) 0.54; 95% confidence interval (CI) 0.36\u20130.86]. Individuals who used an equivalent of at least 1 aspirin a day (\u22657 tablets\/week) were half as likely to have been diagnosed with esophageal carcinoma (aOR 0.47; 95% CI 0.26\u20130.85), and a linear trend was noted with increasing frequency of use (<jats:italic>p<\/jats:italic><jats:sub>trend<\/jats:sub> 0.007). Similar protective effects were noted with \u226420 years of use, whereas no risk reduction was noted with &gt;20 years of use. Consistent reduction in risk associated with aspirin use was noted among both the major histological subtypes, but the protective effect appears to be more pronounced in adenocarcinoma compared to squamous cell carcinoma. Overall, results from the current study suggest that regular aspirin use may be associated with reduced risk of esophageal cancer. \u00a9 2006 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ijc.21814","type":"journal-article","created":{"date-parts":[[2006,1,31]],"date-time":"2006-01-31T22:18:15Z","timestamp":1138745895000},"page":"202-207","source":"Crossref","is-referenced-by-count":31,"title":["Regular aspirin use and esophageal cancer risk"],"prefix":"10.1002","volume":"119","author":[{"given":"Vijayvel","family":"Jayaprakash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi J.","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind M.","family":"Javle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nachimuthu","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten B.","family":"Moysich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,4,17]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.1.10"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.2.74"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg754"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2"},{"key":"e_1_2_5_6_2","unstructured":"SEER Program Public Use Data Tapes 1973\u20131999. Surveillance Research Program 2002 DCCPS NCI."},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910540309"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1998.tb00646.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2004.04.021"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1055-3207(02)00002-9"},{"key":"e_1_2_5_11_2","first-page":"85","article-title":"Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma","volume":"4","author":"Vaughan TL","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djg047"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.17.1277"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655202762671215"},{"key":"e_1_2_5_15_2","first-page":"2","article-title":"The changing epidemiology of esophageal cancer","volume":"26","author":"Blot WJ","year":"1999","journal-title":"Semin Oncol"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880201)61:3<612::AID-CNCR2820610332>3.0.CO;2-Q"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji024"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.15.1972"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112053252301"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199509073331001"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200007000-00003"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690651"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1006\/pmed.1995.1017"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-5325-0_53"},{"key":"e_1_2_5_26_2","first-page":"97","article-title":"Use of aspirin and other nonsteroidal anti\u2010inflammatory drugs and risk of esophageal and gastric cancer","volume":"7","author":"Farrow DC","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_5_27_2","first-page":"933","article-title":"A case\u2010control study of analgesic use and ovarian cancer","volume":"9","author":"Rosenberg L","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1006\/pmed.2001.0945"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1006\/pmed.1999.0518"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199603000-00017"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1159\/000084818"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199403000-00003"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-2-31"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00646-X"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.4.252"},{"key":"e_1_2_5_36_2","first-page":"545","article-title":"Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention","volume":"9","author":"Li M","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_5_37_2","first-page":"705","article-title":"Antitumoral activity of indomethacin on experimental esophageal tumors","volume":"72","author":"Rubio CA","year":"1984","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02554503"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860901)58:5<1029::AID-CNCR2820580508>3.0.CO;2-D"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgh340"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.32371"},{"key":"e_1_2_5_42_2","first-page":"1322","article-title":"Aspirin use and risk of fatal cancer","volume":"53","author":"Thun MJ","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(78)90071-1"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.4.307"},{"key":"e_1_2_5_45_2","first-page":"119","article-title":"Nonsteroidal anti\u2010inflammatory drugs and risk of digestive cancers at sites other than the large bowel","volume":"9","author":"Coogan PF","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7250.1642"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0467"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.2147"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1121"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008469-200006000-00006"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600820"},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I"},{"key":"e_1_2_5_53_2","first-page":"251A","article-title":"Nonsteroidal anti\u2010inflammatory drugs (NSAIDs) use and the risk of subsequent cancer of the upper gastrointestinal tract (UGI)","volume":"43","author":"Peleg ICG","year":"1995","journal-title":"J Investig Med"},{"key":"e_1_2_5_54_2","first-page":"559","article-title":"Aspirin, ibuprofen, and other nonsteroidal anti\u2010inflammatory drugs in cancer prevention: a critical review of nonselective COX\u20102 blockade (review)","volume":"13","author":"Harris RE","year":"2005","journal-title":"Oncol Rep"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-3-28"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50008"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-8663(00)00254-X"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.38.1.97"},{"key":"e_1_2_5_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.20.1529"},{"key":"e_1_2_5_60_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389557033488033"},{"key":"e_1_2_5_61_2","first-page":"2929","article-title":"Increased expression of inducible nitric oxide synthase and cyclooxygenase\u20102 in Barrett's esophagus and associated adenocarcinomas","volume":"58","author":"Wilson KT","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_5_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70254-X"},{"key":"e_1_2_5_63_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.3.297"},{"key":"e_1_2_5_64_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903183401101"},{"key":"e_1_2_5_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01275.x"},{"key":"e_1_2_5_66_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50025"},{"key":"e_1_2_5_67_2","first-page":"171","article-title":"Expression of cyclooxygenase\u20102 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey","volume":"19","author":"Ratnasinghe D","year":"1999","journal-title":"Anticancer Res"},{"key":"e_1_2_5_68_2","first-page":"2268","article-title":"An epidemiological study of precursor lesions of esophageal cancer among young persons in a high\u2010risk population in Huixian, China","volume":"50","author":"Chang\u2010Claude JC","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_5_69_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-2-18"},{"key":"e_1_2_5_70_2","first-page":"903","article-title":"Regular use of analgesic drugs and ovarian cancer risk","volume":"10","author":"Moysich KB","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_5_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D"},{"key":"e_1_2_5_72_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-004-3074-9"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.21814","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.21814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T20:33:04Z","timestamp":1695933184000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.21814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,17]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["10.1002\/ijc.21814"],"URL":"https:\/\/doi.org\/10.1002\/ijc.21814","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,17]]}}}